(Q53255741)

English

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

scientific article published on 6 April 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

title

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

0 references

1 reference

Martin A Cheever

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

Celestia S Higano

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

language of work or name

English

0 references

publication date

6 April 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

published in

Clinical Cancer Research

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

volume

17

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

page(s)

3520-3526

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

Identifiers

DOI

10.1158/1078-0432.CCR-10-3126

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

PubMed publication ID

21471425

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21471425

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21471425

ResearchGate publication ID

51030740

0 references

(Q53255741)

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)